Skip to main content

Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.

Publication ,  Journal Article
Daly, MB; Pilarski, R; Axilbund, JE; Buys, SS; Crawford, B; Friedman, S; Garber, JE; Horton, C; Kaklamani, V; Klein, C; Kohlmann, W; Kurian, A ...
Published in: J Natl Compr Canc Netw
September 2014

During the past few years, several genetic aberrations that may contribute to increased risks for development of breast and/or ovarian cancers have been identified. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian focus specifically on the assessment of genetic mutations in BRCA1/BRCA2, TP53, and PTEN, and recommend approaches to genetic testing/counseling and management strategies in individuals with these mutations. This portion of the NCCN Guidelines includes recommendations regarding diagnostic criteria and management of patients with Cowden Syndrome/PTEN hamartoma tumor syndrome.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

September 2014

Volume

12

Issue

9

Start / End Page

1326 / 1338

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Hamartoma Syndrome, Multiple
  • Germ-Line Mutation
  • Genetic Testing
  • Genetic Counseling
  • Female
  • Disease Management
  • 4203 Health services and systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Daly, M. B., Pilarski, R., Axilbund, J. E., Buys, S. S., Crawford, B., Friedman, S., … National comprehensive cancer network, . (2014). Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw, 12(9), 1326–1338. https://doi.org/10.6004/jnccn.2014.0127
Daly, Mary B., Robert Pilarski, Jennifer E. Axilbund, Saundra S. Buys, Beth Crawford, Susan Friedman, Judy E. Garber, et al. “Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.J Natl Compr Canc Netw 12, no. 9 (September 2014): 1326–38. https://doi.org/10.6004/jnccn.2014.0127.
Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, et al. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw. 2014 Sep;12(9):1326–38.
Daly, Mary B., et al. “Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.J Natl Compr Canc Netw, vol. 12, no. 9, Sept. 2014, pp. 1326–38. Pubmed, doi:10.6004/jnccn.2014.0127.
Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R, National comprehensive cancer network. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw. 2014 Sep;12(9):1326–1338.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

September 2014

Volume

12

Issue

9

Start / End Page

1326 / 1338

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Male
  • Humans
  • Hamartoma Syndrome, Multiple
  • Germ-Line Mutation
  • Genetic Testing
  • Genetic Counseling
  • Female
  • Disease Management
  • 4203 Health services and systems